SCHEMBL18616637

SCHEMBL18616637

N#CC1(NC(=O)C2(NC(=O)c3cc4ccc(-c5ccc6c(c5)CCS6(=O)=O)cc4o3)CCC(F)(F)CC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.38
▸ CTSS P25774 1/20 0.32
▸ CTSK P43235 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20335424 0.93 CTSL (0.39) CTSLCTSSCTSK
SCHEMBL20341853 0.86 CTSL (0.32) CTSLCTSSCTSKPTGDR2
SCHEMBL18615956 0.85 CTSL (0.36) CTSLCTSSCTSK
SCHEMBL18616686 0.84 CTSL (0.38) CTSLCTSSCTSK
SCHEMBL20341771 0.83 CTSL (0.38) CTSLCTSSCTSK
SCHEMBL18616557 0.83 CTSL (0.38) CTSLCTSSCTSK
SCHEMBL20335446 0.83 CTSL (0.36) CTSLCTSSCTSK
SCHEMBL20341772 0.83 CTSL (0.39) CTSLCTSSCTSK
SCHEMBL18615963 0.82 CTSL (0.36) CTSLCTSSCTSK
SCHEMBL18616639 0.82 CTSL (0.36) CTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342765-B1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-09-15 — — EP disclosed
EP-3342765-B1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-09-15 — — EP disclosed
EP-3342765-A1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2018-07-04 — — EP disclosed
EP-3342765-A1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2018-07-04 — — EP disclosed
WO-2017036357-A1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF 广东东阳光药业有限公司 2017-03-09 — — WO disclosed
Send feedback